Literature DB >> 23610419

Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation.

Masatoshi Aida1, Nesreen Hamad, Andre Stanlie, Nasim A Begum, Tasuku Honjo.   

Abstract

Somatic hypermutation (SHM) requires not only the expression of activation-induced cytidine deaminase, but also transcription in the target regions. However, how transcription guides activation-induced cytidine deaminase in targeting SHM to the Ig genes is not fully understood. Here, we found that the "facilitates chromatin transcription" (FACT) complex promotes SHM by RNAi screening of transcription elongation factors. Furthermore, FACT and histone H3.3, a hallmark of transcription-coupled histone turnover, are enriched at the V(D)J region, 5' flanking sequence of the Sμ switch region and the light chain Jκ 5 segment region in the Ig loci. The regions with the most abundant deposition of FACT and H3.3 were also the most efficient targets of SHM. These results demonstrate the importance of histone-exchanging dynamics at the chromatin of SHM targets, especially in Ig genes.

Entities:  

Keywords:  AID; SSRP1

Mesh:

Substances:

Year:  2013        PMID: 23610419      PMCID: PMC3651492          DOI: 10.1073/pnas.1305859110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo.

Authors:  Abbie Saunders; Janis Werner; Erik D Andrulis; Takahiro Nakayama; Susumu Hirose; Danny Reinberg; John T Lis
Journal:  Science       Date:  2003-08-22       Impact factor: 47.728

Review 2.  Class-switch recombination: interplay of transcription, DNA deamination and DNA repair.

Authors:  Jayanta Chaudhuri; Frederick W Alt
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 3.  Non-B DNA conformations, genomic rearrangements, and human disease.

Authors:  Albino Bacolla; Robert D Wells
Journal:  J Biol Chem       Date:  2004-08-23       Impact factor: 5.157

Review 4.  Elongation by RNA polymerase II: the short and long of it.

Authors:  Robert J Sims; Rimma Belotserkovskaya; Danny Reinberg
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

Review 5.  DNA polymerases and somatic hypermutation of immunoglobulin genes.

Authors:  Mineaki Seki; Patricia J Gearhart; Richard D Wood
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

6.  Folding of the DNA double helix in chromatin-like structures from simian virus 40.

Authors:  J E Germond; B Hirt; P Oudet; M Gross-Bellark; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

7.  Drosophila GAGA factor directs histone H3.3 replacement that prevents the heterochromatin spreading.

Authors:  Takahiro Nakayama; Kenichi Nishioka; Yi-Xin Dong; Tsukasa Shimojima; Susumu Hirose
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

8.  FACT, a factor that facilitates transcript elongation through nucleosomes.

Authors:  G Orphanides; G LeRoy; C H Chang; D S Luse; D Reinberg
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

Review 9.  Role of AID in tumorigenesis.

Authors:  Il-mi Okazaki; Ai Kotani; Tasuku Honjo
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

10.  Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis.

Authors:  Hideaki Tagami; Dominique Ray-Gallet; Geneviève Almouzni; Yoshihiro Nakatani
Journal:  Cell       Date:  2004-01-09       Impact factor: 41.582

View more
  16 in total

1.  Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.

Authors:  Alina Tarsalainen; Yaakov Maman; Fei-Long Meng; Minna K Kyläniemi; Anni Soikkeli; Paulina Budzyńska; Jessica J McDonald; Filip Šenigl; Frederic W Alt; David G Schatz; Jukka Alinikula
Journal:  J Immunol       Date:  2021-12-03       Impact factor: 5.422

Review 2.  Generation and repair of AID-initiated DNA lesions in B lymphocytes.

Authors:  Zhangguo Chen; Jing H Wang
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

Review 3.  Regulating infidelity: RNA-mediated recruitment of AID to DNA during class switch recombination.

Authors:  Lauren J DiMenna; Jayanta Chaudhuri
Journal:  Eur J Immunol       Date:  2016-02-22       Impact factor: 5.532

Review 4.  Histone H3.3 mutations: a variant path to cancer.

Authors:  Benjamin T K Yuen; Paul S Knoepfler
Journal:  Cancer Cell       Date:  2013-11-11       Impact factor: 31.743

5.  The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.

Authors:  Guojun Yu; Yongwei Zhang; Varun Gupta; Jinghang Zhang; Thomas MacCarthy; Zhi Duan; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

Review 6.  Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response.

Authors:  Hong Zan; Paolo Casali
Journal:  Front Immunol       Date:  2015-12-14       Impact factor: 7.561

7.  The yeast and human FACT chromatin-reorganizing complexes solve R-loop-mediated transcription-replication conflicts.

Authors:  Emilia Herrera-Moyano; Xénia Mergui; María L García-Rubio; Sonia Barroso; Andrés Aguilera
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

8.  Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes.

Authors:  Zhi Duan; Linda B Baughn; Xiaohua Wang; Yongwei Zhang; Varun Gupta; Thomas MacCarthy; Matthew D Scharff; Guojun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

9.  The PML-Interacting Protein DAXX: Histone Loading Gets into the Picture.

Authors:  Paolo Salomoni
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

10.  FACT and H3.3: new markers for the somatic hypermutation.

Authors:  Masatoshi Aida; Tasuku Honjo
Journal:  Cell Cycle       Date:  2013-08-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.